Pediatrix Medical (MD) Accumulated Depreciation & Amortization (2010 - 2025)

Pediatrix Medical (MD) has 16 years of Accumulated Depreciation & Amortization data on file, last reported at $132.3 million in Q4 2025.

• Quarterly Accumulated Depreciation & Amortization rose 4.61% year-over-year to $132.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $132.3 million (up 4.61% YoY) and the FY2025 annual result came in at $132.3 million, up 4.61% from the prior year.
• Accumulated Depreciation & Amortization advanced to $132.3 million in Q4 2025 per MD's latest filing, from $126.5 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $172.2 million in Q4 2022 and bottomed at $126.5 million in Q4 2024.
• The 5-year median for Accumulated Depreciation & Amortization is $142.7 million (2023), against an average of $147.7 million.
• The widest annual swing landed in 2021, when Accumulated Depreciation & Amortization soared 479.05%; it then slipped 17.13% in 2023.
• Tracing MD's Accumulated Depreciation & Amortization over 5 years: stood at $164.7 million in 2021, then climbed by 4.57% to $172.2 million in 2022, then decreased by 17.13% to $142.7 million in 2023, then decreased by 11.36% to $126.5 million in 2024, then climbed by 4.61% to $132.3 million in 2025.
• Per Business Quant, the three latest MD Accumulated Depreciation & Amortization figures stand at $132.3 million (Q4 2025), $126.5 million (Q4 2024), and $142.7 million (Q4 2023).

Peer Comparison